1 Market Overview
    1.1 Product Overview and Scope of Chronic Obstructive Pulmonary Disorder
    1.2 Classification of Chronic Obstructive Pulmonary Disorder by Type
        1.2.1 Overview: Global Chronic Obstructive Pulmonary Disorder Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Chronic Obstructive Pulmonary Disorder Revenue Market Share by Type in 2020
        1.2.3 Short-Acting Bronchodilators
        1.2.4 Corticosteroids
        1.2.5 Methylxanthines
        1.2.6 Long-Acting Bronchodilators
        1.2.7 Phosphodiesterase-4 Inhibitors
        1.2.8 Others
    1.3 Global Chronic Obstructive Pulmonary Disorder Market by Application
        1.3.1 Overview: Global Chronic Obstructive Pulmonary Disorder Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Global Chronic Obstructive Pulmonary Disorder Market Size & Forecast
    1.5 Global Chronic Obstructive Pulmonary Disorder Market Size and Forecast by Region
        1.5.1 Global Chronic Obstructive Pulmonary Disorder Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Chronic Obstructive Pulmonary Disorder Market Size by Region, (2016-2021)
        1.5.3 North America Chronic Obstructive Pulmonary Disorder Market Size and Prospect (2016-2026)
        1.5.4 Europe Chronic Obstructive Pulmonary Disorder Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size and Prospect (2016-2026)
        1.5.6 South America Chronic Obstructive Pulmonary Disorder Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Chronic Obstructive Pulmonary Disorder Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Chronic Obstructive Pulmonary Disorder Market Drivers
        1.6.2 Chronic Obstructive Pulmonary Disorder Market Restraints
        1.6.3 Chronic Obstructive Pulmonary Disorder Trends Analysis
2 Company Profiles
    2.1 GSK
        2.1.1 GSK Details
        2.1.2 GSK Major Business
        2.1.3 GSK Chronic Obstructive Pulmonary Disorder Product and Solutions
        2.1.4 GSK Chronic Obstructive Pulmonary Disorder Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 GSK Recent Developments and Future Plans
    2.2 Pfizer
        2.2.1 Pfizer Details
        2.2.2 Pfizer Major Business
        2.2.3 Pfizer Chronic Obstructive Pulmonary Disorder Product and Solutions
        2.2.4 Pfizer Chronic Obstructive Pulmonary Disorder Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Pfizer Recent Developments and Future Plans
    2.3 Merck
        2.3.1 Merck Details
        2.3.2 Merck Major Business
        2.3.3 Merck Chronic Obstructive Pulmonary Disorder Product and Solutions
        2.3.4 Merck Chronic Obstructive Pulmonary Disorder Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Merck Recent Developments and Future Plans
    2.4 Novartis
        2.4.1 Novartis Details
        2.4.2 Novartis Major Business
        2.4.3 Novartis Chronic Obstructive Pulmonary Disorder Product and Solutions
        2.4.4 Novartis Chronic Obstructive Pulmonary Disorder Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Novartis Recent Developments and Future Plans
    2.5 AstraZeneca
        2.5.1 AstraZeneca Details
        2.5.2 AstraZeneca Major Business
        2.5.3 AstraZeneca Chronic Obstructive Pulmonary Disorder Product and Solutions
        2.5.4 AstraZeneca Chronic Obstructive Pulmonary Disorder Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 AstraZeneca Recent Developments and Future Plans
    2.6 Boehringer Ingelheim
        2.6.1 Boehringer Ingelheim Details
        2.6.2 Boehringer Ingelheim Major Business
        2.6.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder Product and Solutions
        2.6.4 Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Boehringer Ingelheim Recent Developments and Future Plans
    2.7 Teva Pharmaceuticals
        2.7.1 Teva Pharmaceuticals Details
        2.7.2 Teva Pharmaceuticals Major Business
        2.7.3 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder Product and Solutions
        2.7.4 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Teva Pharmaceuticals Recent Developments and Future Plans
    2.8 Ario Pharma
        2.8.1 Ario Pharma Details
        2.8.2 Ario Pharma Major Business
        2.8.3 Ario Pharma Chronic Obstructive Pulmonary Disorder Product and Solutions
        2.8.4 Ario Pharma Chronic Obstructive Pulmonary Disorder Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Ario Pharma Recent Developments and Future Plans
    2.9 Roche
        2.9.1 Roche Details
        2.9.2 Roche Major Business
        2.9.3 Roche Chronic Obstructive Pulmonary Disorder Product and Solutions
        2.9.4 Roche Chronic Obstructive Pulmonary Disorder Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Roche Recent Developments and Future Plans
    2.10 Ache 
        2.10.1 Ache Details
        2.10.2 Ache Major Business
        2.10.3 Ache Chronic Obstructive Pulmonary Disorder Product and Solutions
        2.10.4 Ache Chronic Obstructive Pulmonary Disorder Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Ache Recent Developments and Future Plans
    2.11 Almirall
        2.11.1 Almirall Details
        2.11.2 Almirall Major Business
        2.11.3 Almirall Chronic Obstructive Pulmonary Disorder Product and Solutions
        2.11.4 Almirall Chronic Obstructive Pulmonary Disorder Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Almirall Recent Developments and Future Plans
    2.12 Aquinox Pharmaceuticals
        2.12.1 Aquinox Pharmaceuticals Details
        2.12.2 Aquinox Pharmaceuticals Major Business
        2.12.3 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder Product and Solutions
        2.12.4 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Aquinox Pharmaceuticals Recent Developments and Future Plans
    2.13 Asmacure
        2.13.1 Asmacure Details
        2.13.2 Asmacure Major Business
        2.13.3 Asmacure Chronic Obstructive Pulmonary Disorder Product and Solutions
        2.13.4 Asmacure Chronic Obstructive Pulmonary Disorder Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Asmacure Recent Developments and Future Plans
    2.14 Astellas Pharma
        2.14.1 Astellas Pharma Details
        2.14.2 Astellas Pharma Major Business
        2.14.3 Astellas Pharma Chronic Obstructive Pulmonary Disorder Product and Solutions
        2.14.4 Astellas Pharma Chronic Obstructive Pulmonary Disorder Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Astellas Pharma Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Chronic Obstructive Pulmonary Disorder Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Chronic Obstructive Pulmonary Disorder Players Market Share
        3.2.2 Top 10 Chronic Obstructive Pulmonary Disorder Players Market Share
        3.2.3 Market Competition Trend
    3.3 Chronic Obstructive Pulmonary Disorder Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Chronic Obstructive Pulmonary Disorder Revenue and Market Share by Type (2016-2021)
    4.2 Global Chronic Obstructive Pulmonary Disorder Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Chronic Obstructive Pulmonary Disorder Revenue Market Share by Application (2016-2021)
    5.2 Chronic Obstructive Pulmonary Disorder Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Chronic Obstructive Pulmonary Disorder Revenue by Type (2016-2026)
    6.2 North America Chronic Obstructive Pulmonary Disorder Revenue by Application (2016-2026)
    6.3 North America Chronic Obstructive Pulmonary Disorder Market Size by Country
        6.3.1 North America Chronic Obstructive Pulmonary Disorder Revenue by Country (2016-2026)
        6.3.2 United States Chronic Obstructive Pulmonary Disorder Market Size and Forecast (2016-2026)
        6.3.3 Canada Chronic Obstructive Pulmonary Disorder Market Size and Forecast (2016-2026)
        6.3.4 Mexico Chronic Obstructive Pulmonary Disorder Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Chronic Obstructive Pulmonary Disorder Revenue by Type (2016-2026)
    7.2 Europe Chronic Obstructive Pulmonary Disorder Revenue by Application (2016-2026)
    7.3 Europe Chronic Obstructive Pulmonary Disorder Market Size by Country
        7.3.1 Europe Chronic Obstructive Pulmonary Disorder Revenue by Country (2016-2026)
        7.3.2 Germany Chronic Obstructive Pulmonary Disorder Market Size and Forecast (2016-2026)
        7.3.3 France Chronic Obstructive Pulmonary Disorder Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Chronic Obstructive Pulmonary Disorder Market Size and Forecast (2016-2026)
        7.3.5 Russia Chronic Obstructive Pulmonary Disorder Market Size and Forecast (2016-2026)
        7.3.6 Italy Chronic Obstructive Pulmonary Disorder Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder Revenue by Type (2016-2026)
    8.2 Asia-Pacific Chronic Obstructive Pulmonary Disorder Revenue by Application (2016-2026)
    8.3 Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size by Region
        8.3.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder Revenue by Region (2016-2026)
        8.3.2 China Chronic Obstructive Pulmonary Disorder Market Size and Forecast (2016-2026)
        8.3.3 Japan Chronic Obstructive Pulmonary Disorder Market Size and Forecast (2016-2026)
        8.3.4 South Korea Chronic Obstructive Pulmonary Disorder Market Size and Forecast (2016-2026)
        8.3.5 India Chronic Obstructive Pulmonary Disorder Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size and Forecast (2016-2026)
        8.3.7 Australia Chronic Obstructive Pulmonary Disorder Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Chronic Obstructive Pulmonary Disorder Revenue by Type (2016-2026)
    9.2 South America Chronic Obstructive Pulmonary Disorder Revenue by Application (2016-2026)
    9.3 South America Chronic Obstructive Pulmonary Disorder Market Size by Country
        9.3.1 South America Chronic Obstructive Pulmonary Disorder Revenue by Country (2016-2026)
        9.3.2 Brazil Chronic Obstructive Pulmonary Disorder Market Size and Forecast (2016-2026)
        9.3.3 Argentina Chronic Obstructive Pulmonary Disorder Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder Revenue by Type (2016-2026)
    10.2 Middle East & Africa Chronic Obstructive Pulmonary Disorder Revenue by Application (2016-2026)
    10.3 Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size by Country
        10.3.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder Revenue by Country (2016-2026)
        10.3.2 Turkey Chronic Obstructive Pulmonary Disorder Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Chronic Obstructive Pulmonary Disorder Market Size and Forecast (2016-2026)
        10.3.4 UAE Chronic Obstructive Pulmonary Disorder Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Chronic Obstructive Pulmonary Disorder Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Chronic Obstructive Pulmonary Disorder Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Chronic Obstructive Pulmonary Disorder Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Chronic Obstructive Pulmonary Disorder Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Chronic Obstructive Pulmonary Disorder Revenue Market Share by Region (2021-2026)
    Table 6. GSK Corporate Information, Head Office, and Major Competitors
    Table 7. GSK Major Business
    Table 8. GSK Chronic Obstructive Pulmonary Disorder Product and Solutions
    Table 9. GSK Chronic Obstructive Pulmonary Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Pfizer Corporate Information, Head Office, and Major Competitors
    Table 11. Pfizer Major Business
    Table 12. Pfizer Chronic Obstructive Pulmonary Disorder Product and Solutions
    Table 13. Pfizer Chronic Obstructive Pulmonary Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Merck Corporate Information, Head Office, and Major Competitors
    Table 15. Merck Major Business
    Table 16. Merck Chronic Obstructive Pulmonary Disorder Product and Solutions
    Table 17. Merck Chronic Obstructive Pulmonary Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Novartis Corporate Information, Head Office, and Major Competitors
    Table 19. Novartis Major Business
    Table 20. Novartis Chronic Obstructive Pulmonary Disorder Product and Solutions
    Table 21. Novartis Chronic Obstructive Pulmonary Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. AstraZeneca Corporate Information, Head Office, and Major Competitors
    Table 23. AstraZeneca Major Business
    Table 24. AstraZeneca Chronic Obstructive Pulmonary Disorder Product and Solutions
    Table 25. AstraZeneca Chronic Obstructive Pulmonary Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
    Table 27. Boehringer Ingelheim Major Business
    Table 28. Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder Product and Solutions
    Table 29. Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Teva Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 31. Teva Pharmaceuticals Major Business
    Table 32. Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder Product and Solutions
    Table 33. Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Ario Pharma Corporate Information, Head Office, and Major Competitors
    Table 35. Ario Pharma Major Business
    Table 36. Ario Pharma Chronic Obstructive Pulmonary Disorder Product and Solutions
    Table 37. Ario Pharma Chronic Obstructive Pulmonary Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Roche Corporate Information, Head Office, and Major Competitors
    Table 39. Roche Major Business
    Table 40. Roche Chronic Obstructive Pulmonary Disorder Product and Solutions
    Table 41. Roche Chronic Obstructive Pulmonary Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Ache Corporate Information, Head Office, and Major Competitors
    Table 43. Ache Major Business
    Table 44. Ache Chronic Obstructive Pulmonary Disorder Product and Solutions
    Table 45. Ache Chronic Obstructive Pulmonary Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. Almirall Corporate Information, Head Office, and Major Competitors
    Table 47. Almirall Major Business
    Table 48. Almirall Chronic Obstructive Pulmonary Disorder Product and Solutions
    Table 49. Almirall Chronic Obstructive Pulmonary Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. Aquinox Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 51. Aquinox Pharmaceuticals Major Business
    Table 52. Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder Product and Solutions
    Table 53. Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. Asmacure Corporate Information, Head Office, and Major Competitors
    Table 55. Asmacure Major Business
    Table 56. Asmacure Chronic Obstructive Pulmonary Disorder Product and Solutions
    Table 57. Asmacure Chronic Obstructive Pulmonary Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 58. Astellas Pharma Corporate Information, Head Office, and Major Competitors
    Table 59. Astellas Pharma Major Business
    Table 60. Astellas Pharma Chronic Obstructive Pulmonary Disorder Product and Solutions
    Table 61. Astellas Pharma Chronic Obstructive Pulmonary Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 62. Global Chronic Obstructive Pulmonary Disorder Revenue (USD Million) by Players (2019-2021)
    Table 63. Global Chronic Obstructive Pulmonary Disorder Revenue Share by Players (2019-2021)
    Table 64. Breakdown of Chronic Obstructive Pulmonary Disorder by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 65. Chronic Obstructive Pulmonary Disorder Players Head Office, Products and Services Provided
    Table 66. Chronic Obstructive Pulmonary Disorder Mergers & Acquisitions in the Past Five Years
    Table 67. Chronic Obstructive Pulmonary Disorder New Entrants and Expansion Plans
    Table 68. Global Chronic Obstructive Pulmonary Disorder Revenue (USD Million) by Type (2016-2021)
    Table 69. Global Chronic Obstructive Pulmonary Disorder Revenue Share by Type (2016-2021)
    Table 70. Global Chronic Obstructive Pulmonary Disorder Revenue Forecast by Type (2021-2026)
    Table 71. Global Chronic Obstructive Pulmonary Disorder Revenue by Application (2016-2021)
    Table 72. Global Chronic Obstructive Pulmonary Disorder Revenue Forecast by Application (2021-2026)
    Table 73. North America Chronic Obstructive Pulmonary Disorder Revenue by Type (2016-2021) & (USD Million)
    Table 74. North America Chronic Obstructive Pulmonary Disorder Revenue by Type (2021-2026) & (USD Million)
    Table 75. North America Chronic Obstructive Pulmonary Disorder Revenue by Application (2016-2021) & (USD Million)
    Table 76. North America Chronic Obstructive Pulmonary Disorder Revenue by Application (2021-2026) & (USD Million)
    Table 77. North America Chronic Obstructive Pulmonary Disorder Revenue by Country (2016-2021) & (USD Million)
    Table 78. North America Chronic Obstructive Pulmonary Disorder Revenue by Country (2021-2026) & (USD Million)
    Table 79. Europe Chronic Obstructive Pulmonary Disorder Revenue by Type (2016-2021) & (USD Million)
    Table 80. Europe Chronic Obstructive Pulmonary Disorder Revenue by Type (2021-2026) & (USD Million)
    Table 81. Europe Chronic Obstructive Pulmonary Disorder Revenue by Application (2016-2021) & (USD Million)
    Table 82. Europe Chronic Obstructive Pulmonary Disorder Revenue by Application (2021-2026) & (USD Million)
    Table 83. Europe Chronic Obstructive Pulmonary Disorder Revenue by Country (2016-2021) & (USD Million)
    Table 84. Europe Chronic Obstructive Pulmonary Disorder Revenue by Country (2021-2026) & (USD Million)
    Table 85. Asia-Pacific Chronic Obstructive Pulmonary Disorder Revenue by Type (2016-2021) & (USD Million)
    Table 86. Asia-Pacific Chronic Obstructive Pulmonary Disorder Revenue by Type (2021-2026) & (USD Million)
    Table 87. Asia-Pacific Chronic Obstructive Pulmonary Disorder Revenue by Application (2016-2021) & (USD Million)
    Table 88. Asia-Pacific Chronic Obstructive Pulmonary Disorder Revenue by Application (2021-2026) & (USD Million)
    Table 89. Asia-Pacific Chronic Obstructive Pulmonary Disorder Revenue by Region (2016-2021) & (USD Million)
    Table 90. Asia-Pacific Chronic Obstructive Pulmonary Disorder Revenue by Region (2021-2026) & (USD Million)
    Table 91. South America Chronic Obstructive Pulmonary Disorder Revenue by Type (2016-2021) & (USD Million)
    Table 92. South America Chronic Obstructive Pulmonary Disorder Revenue by Type (2021-2026) & (USD Million)
    Table 93. South America Chronic Obstructive Pulmonary Disorder Revenue by Application (2016-2021) & (USD Million)
    Table 94. South America Chronic Obstructive Pulmonary Disorder Revenue by Application (2021-2026) & (USD Million)
    Table 95. South America Chronic Obstructive Pulmonary Disorder Revenue by Country (2016-2021) & (USD Million)
    Table 96. South America Chronic Obstructive Pulmonary Disorder Revenue by Country (2021-2026) & (USD Million)
    Table 97. Middle East & Africa Chronic Obstructive Pulmonary Disorder Revenue by Type (2016-2021) & (USD Million)
    Table 98. Middle East & Africa Chronic Obstructive Pulmonary Disorder Revenue by Type (2021-2026) & (USD Million)
    Table 99. Middle East & Africa Chronic Obstructive Pulmonary Disorder Revenue by Application (2016-2021) & (USD Million)
    Table 100. Middle East & Africa Chronic Obstructive Pulmonary Disorder Revenue by Application (2021-2026) & (USD Million)
    Table 101. Middle East & Africa Chronic Obstructive Pulmonary Disorder Revenue by Country (2016-2021) & (USD Million)
    Table 102. Middle East & Africa Chronic Obstructive Pulmonary Disorder Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Chronic Obstructive Pulmonary Disorder Picture
    Figure 2. Global Chronic Obstructive Pulmonary Disorder Revenue Market Share by Type in 2020
    Figure 3. Short-Acting Bronchodilators
    Figure 4. Corticosteroids
    Figure 5. Methylxanthines
    Figure 6. Long-Acting Bronchodilators
    Figure 7. Phosphodiesterase-4 Inhibitors
    Figure 8. Others
    Figure 9. Chronic Obstructive Pulmonary Disorder Revenue Market Share by Application in 2020
    Figure 10. Hospitals Picture
    Figure 11. Clinics Picture
    Figure 12. Others Picture
    Figure 13. Global Chronic Obstructive Pulmonary Disorder Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 14. Global Chronic Obstructive Pulmonary Disorder Revenue and Forecast (2016-2026) & (USD Million)
    Figure 15. Global Chronic Obstructive Pulmonary Disorder Revenue Market Share by Region (2016-2026)
    Figure 16. Global Chronic Obstructive Pulmonary Disorder Revenue Market Share by Region in 2020
    Figure 17. North America Chronic Obstructive Pulmonary Disorder Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Europe Chronic Obstructive Pulmonary Disorder Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. Asia-Pacific Chronic Obstructive Pulmonary Disorder Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 20. South America Chronic Obstructive Pulmonary Disorder Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 21. Middle East and Africa Chronic Obstructive Pulmonary Disorder Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 22. Chronic Obstructive Pulmonary Disorder Market Drivers
    Figure 23. Chronic Obstructive Pulmonary Disorder Market Restraints
    Figure 24. Chronic Obstructive Pulmonary Disorder Market Trends
    Figure 25. GSK Recent Developments and Future Plans
    Figure 26. Pfizer Recent Developments and Future Plans
    Figure 27. Merck Recent Developments and Future Plans
    Figure 28. Novartis Recent Developments and Future Plans
    Figure 29. AstraZeneca Recent Developments and Future Plans
    Figure 30. Boehringer Ingelheim Recent Developments and Future Plans
    Figure 31. Teva Pharmaceuticals Recent Developments and Future Plans
    Figure 32. Ario Pharma Recent Developments and Future Plans
    Figure 33. Roche Recent Developments and Future Plans
    Figure 34. Ache Recent Developments and Future Plans
    Figure 35. Almirall Recent Developments and Future Plans
    Figure 36. Aquinox Pharmaceuticals Recent Developments and Future Plans
    Figure 37. Asmacure Recent Developments and Future Plans
    Figure 38. Astellas Pharma Recent Developments and Future Plans
    Figure 39. Global Chronic Obstructive Pulmonary Disorder Revenue Share by Players in 2020
    Figure 40. Chronic Obstructive Pulmonary Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 41. Global Top 3 Players Chronic Obstructive Pulmonary Disorder Revenue Market Share in 2020
    Figure 42. Global Top 10 Players Chronic Obstructive Pulmonary Disorder Revenue Market Share in 2020
    Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 44. Global Chronic Obstructive Pulmonary Disorder Revenue Share by Type in 2020
    Figure 45. Global Chronic Obstructive Pulmonary Disorder Market Share Forecast by Type (2021-2026)
    Figure 46. Global Chronic Obstructive Pulmonary Disorder Revenue Share by Application in 2020
    Figure 47. Global Chronic Obstructive Pulmonary Disorder Market Share Forecast by Application (2021-2026)
    Figure 48. North America Chronic Obstructive Pulmonary Disorder Sales Market Share by Type (2016-2026)
    Figure 49. North America Chronic Obstructive Pulmonary Disorder Sales Market Share by Application (2016-2026)
    Figure 50. North America Chronic Obstructive Pulmonary Disorder Revenue Market Share by Country (2016-2026)
    Figure 51. United States Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Canada Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Mexico Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. Europe Chronic Obstructive Pulmonary Disorder Sales Market Share by Type (2016-2026)
    Figure 55. Europe Chronic Obstructive Pulmonary Disorder Sales Market Share by Application (2016-2026)
    Figure 56. Europe Chronic Obstructive Pulmonary Disorder Revenue Market Share by Country (2016-2026)
    Figure 57. Germany Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. France Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. United Kingdom Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Russia Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Italy Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Asia-Pacific Chronic Obstructive Pulmonary Disorder Sales Market Share by Type (2016-2026)
    Figure 63. Asia-Pacific Chronic Obstructive Pulmonary Disorder Sales Market Share by Application (2016-2026)
    Figure 64. Asia-Pacific Chronic Obstructive Pulmonary Disorder Revenue Market Share by Region (2016-2026)
    Figure 65. China Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. Japan Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. South Korea Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. India Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Southeast Asia Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. Australia Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 71. South America Chronic Obstructive Pulmonary Disorder Sales Market Share by Type (2016-2026)
    Figure 72. South America Chronic Obstructive Pulmonary Disorder Sales Market Share by Application (2016-2026)
    Figure 73. South America Chronic Obstructive Pulmonary Disorder Revenue Market Share by Country (2016-2026)
    Figure 74. Brazil Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Argentina Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. Middle East and Africa Chronic Obstructive Pulmonary Disorder Sales Market Share by Type (2016-2026)
    Figure 77. Middle East and Africa Chronic Obstructive Pulmonary Disorder Sales Market Share by Application (2016-2026)
    Figure 78. Middle East and Africa Chronic Obstructive Pulmonary Disorder Revenue Market Share by Country (2016-2026)
    Figure 79. Turkey Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 80. Saudi Arabia Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 81. UAE Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 82. Methodology
    Figure 83. Research Process and Data Source